Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)

Fig. 2

Reports related to adverse events (AEs) associated with the olanzapine/samidorphan combination within various System Organ Classes (SOCs). (A) Bar plot illustrates the number of AEs related with the olanzapine/samidorphan combination, categorized by SOC. (B) Bar plot displays the preferred terms (PTs) and SOCs associated with AEs related to the olanzapine/samidorphan combination. The colors represent the relationships between different PTs and SOCs

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us